The average price target represents a 32.31% upside from the last price of $13.94. It is understandable that investor optimism is growing ahead of the companys current quarter results. Viatris Inc () Stock Market info Recommendations: Buy or sell Viatris stock? What is Viatris stock price? Viatris stock price prediction is an act of determining the future value of Viatris shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. Complete Viatris Inc. stock information by Barron's. Get Viatris Inc (VTRS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. This suggests that the stock has a possible downside of 6.6%.
Viatris Inc. (VTRS) estimates and forecasts. Tuesday, November 30, 2021. Read stock experts recommendations for help on deciding if you should buy, sell or hold the stock.
Generic-drug maker Viatris initiated a dividend on Monday, but VTRS stock plummeted after the company issued a downbeat 2021 outlook.. X. 10 stocks we like better than Viatris Inc.
Viatris stock has appeared in investors' accounts, which has surprised many of them. The Viatris Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. On average, they expect Pfizer's stock price to reach $46.31 in the next twelve months. It is a trending stock that is worth watching. The company reported its fiscal third-quarter revenue and earnings before markets opened, beating analyst expectations on revenue. Gangrene Treatment Drugs Market Overview By Share, Size, Industry Players, Revenue And Product Demand Forecast Till 2029 AmericaNewsHour. Viatris Wins Federal Circuit Court Appeal Upholding District Court Decision Invalidating Biogen's Tecfidera Patent PR Newswire - PRF. The Viatris PE ratio based on its reported earnings over the past 12 months is 3.28.
VTRS updated stock price target summary. Viatris has a current Real Value of $13.74 per share.
Viatris Inc. analyst ratings, historical stock prices, earnings estimates & actuals. It is calculated by dividing a company's price per share by its earnings per share. ET by Tomi Kilgore Barron's Healthcare company Viatris (NASDAQ: VTRS) and oil and gas stock Suncor Energy (NYSE: SU) are two incredibly cheap dividend investments that you can buy and hold. Today 200 Day Moving Average is the resistance level (14.28 $). Viatris is a global pharmaceutical company that believes in healthcare not as it is, but as it should be. Is Viatris worth watching? Summary. Even Viatris' own forecast doesn't project much revenue growth for the next four years. Viatris is a new kind of global healthcare company whose mission is to empower people worldwide to live healthier at every stage of life by expanding access
View real-time VTRS stock price and news, along with industry-best analysis. What this means: InvestorsObserver gives Viatris Inc (VTRS) an overall rank of 27, which is below average. The one-year Viatris Inc. stock forecast points to a potential upside of 35.79. VIATRIS INC. : Forcasts, revenue, earnings, analysts expectations, ratios for VIATRIS INC. Stock | VTRS | US92556V1061 Do the numbers hold clues to what lies ahead for the stock? Piper Sandler doesnt expect the stock to See the dividend dates for Viatris (VTRS) stock dividend yield, Ex-dividend dates, history and payout ratio
4 stock analysts on Stockchase covered Viatris In the last year. The number of outstanding shares for Viatris Inc is 1209290000. 03:58 AM ET. Viatris is the result of a deal involving Mylan and Pfizer. If the price falls in the upcoming period, every price in a range from $10 to $13 could be a very good opportunity to invest in Viatris stock. 12 brokerages have issued twelve-month price targets for Viatris' stock.
The market cap for the stock reached $16.58 billion, with 1.21 billion shares outstanding and 1.20 billion shares in the current float. 4 stock analysts on Stockchase covered Viatris In the last year. Viatris Inc. (NASDAQ: VTRS) was in 55 hedge funds' portfolios at The market cap for the stock reached $15.24 billion, with 1.21 billion shares outstanding and 1.21 billion shares in the current float.
Learn about our story, explore our products and browse career opportunities. Investing.com - Viatris reported on Monday third quarter earnings that missed analysts' forecasts and revenue that topped expectations. Viatris stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
Forecast & Beta.
Webull offers kinds of Viatris Inc stock information, including NASDAQ:VTRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VTRS stock news, and many more online research tools to help you make informed decisions. Based on the current stock market valuations, we can use earnings growth valuation metrics to back into the required growth rate to What is Viatris stock price? Subscribe for free and invest smarter today.
Statistics show that Viatris Inc. has underperformed its competitors in share price, compared to the industry in which it operates. On 2021-12-03, Viatris (VTRS-Q) stock closed at a price of $12.2. Viatris Inc. is expected* to report earnings on 11/08/2021 before market open.
The number of long hedge fund bets went up by 2 lately. The beta value . When our award-winning analyst team has a stock tip, it can pay to listen. It Viatris (VTRS) Q3 Earnings and Revenues Surpass Estimates Zacks - Mon Nov 8, 7:35AM CST .
Complete Viatris Inc. stock information by Barron's. stock was originally listed at a price of $9.31 in Dec 31, 1997. (NASDAQ: VTRS) Viatris's current Earnings Per Share (EPS) is -$2.42. Viatris stock tumbles to pace S&P 500 losers after downbeat revenue, free cash flow outlooks Feb. 22, 2021 at 8:49 a.m. Viatris Inc., which has a market valuation of $17.23 billion, is expected to release its quarterly earnings report Nov 08, 2021. Home Stock forecasts FITB 2023.